Literature DB >> 25112851

Stones: Guidelines reignite interest in medical treatment of stones.

Hans-Göran Tiselius1.   

Abstract

Mesh：

Year:  2014        PMID： 25112851     DOI： 10.1038/nrurol.2014.206

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  8 in total

Review 1.  The history of kidney stone dissolution therapy: 50 years of optimism and frustration with renacidin.

Authors:  Ricardo D Gonzalez; Bryant M Whiting; Benjamin K Canales
Journal:  J Endourol       Date:  2011-10-14       Impact factor: 2.942

2.  Prevalence of 24-hour urine collection in high risk stone formers.

Authors:  Jaclyn C Milose; Samuel R Kaufman; Brent K Hollenbeck; J Stuart Wolf; John M Hollingsworth
Journal:  J Urol       Date:  2013-09-07       Impact factor: 7.450

3.  Medical management of kidney stones: AUA guideline.

Authors:  Margaret S Pearle; David S Goldfarb; Dean G Assimos; Gary Curhan; Cynthia J Denu-Ciocca; Brian R Matlaga; Manoj Monga; Kristina L Penniston; Glenn M Preminger; Thomas M T Turk; James R White
Journal:  J Urol       Date:  2014-05-20       Impact factor: 7.450

4.  Minimally invasive treatment of infection staghorn stones with shock wave lithotripsy and chemolysis.

Authors:  H G Tiselius; E Hellgren; A Andersson; A Borrud-Ohlsson; I Eriksson
Journal:  Scand J Urol Nephrol       Date:  1999-10

Review 5.  Medical management to prevent recurrent nephrolithiasis in adults: a systematic review for an American College of Physicians Clinical Guideline.

Authors:  Howard A Fink; Timothy J Wilt; Keith E Eidman; Pranav S Garimella; Roderick MacDonald; Indulis R Rutks; Michelle Brasure; Robert L Kane; Jeannine Ouellette; Manoj Monga
Journal:  Ann Intern Med       Date:  2013-04-02       Impact factor: 25.391

Review 6.  Is prevention of stone recurrence financially worthwhile?

Authors:  W G Robertson
Journal:  Urol Res       Date:  2006-02-03

7.  Meta-analysis of randomized trials for medical prevention of calcium oxalate nephrolithiasis.

Authors:  M S Pearle; C G Roehrborn; C Y Pak
Journal:  J Endourol       Date:  1999-11       Impact factor: 2.942

Review 8.  Pharmacotherapy of kidney stones.

Authors:  Charles Y C Pak
Journal:  Expert Opin Pharmacother       Date:  2008-06       Impact factor: 3.889
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.